- cafead   Sep 18, 2024 at 11:22: PM
via Upstream Bio, a clinical-stage biotech developing a monoclonal antibody to target respiratory disorders, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering.
article source
article source